Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 145040-37-5 Chemical Structure| 145040-37-5

Structure of Candesartan cilexetil
CAS No.: 145040-37-5

Chemical Structure| 145040-37-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Candesartan Cilexetil is a benzimidazole-derived and competitive AT1 inhibitor with IC50 value of 0.26 nM.

Synonyms: TCV-116; Candesartan M1 Cilexetil

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Candesartan cilexetil

CAS No. :145040-37-5
Formula : C33H34N6O6
M.W : 610.66
SMILES Code : O=C(C1=C2N(CC3=CC=C(C4=CC=CC=C4C5=NNN=N5)C=C3)C(OCC)=NC2=CC=C1)OC(OC(OC6CCCCC6)=O)C
Synonyms :
TCV-116; Candesartan M1 Cilexetil
MDL No. :MFCD00871371
InChI Key :GHOSNRCGJFBJIB-UHFFFAOYSA-N
Pubchem ID :2540

Safety of Candesartan cilexetil

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H360-H362
Precautionary Statements:P501-P263-P260-P270-P202-P201-P264-P280-P308+P313-P405
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Candesartan cilexetil

GPCR

Isoform Comparison

Biological Activity

Target
  • RAAS

    Ang II receptor, IC50:0.26 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Triple-negative breast cancer cells (MDA-MB-231, BT20) IC50 ~18-20μM 4 days Evaluate the effect of Candesartan cilexetil on the viability of triple-negative breast cancer cells, showing significant inhibition of cell proliferation. PMC10066340
Colorectal cancer cells (HT29, HCT116, DLD1) IC50 ~15-17μM 4 days Evaluate the effect of Candesartan cilexetil on the viability of colorectal cancer cells, showing significant inhibition of cell proliferation. PMC10066340
Pancreatic cancer cells (PANC1, MiaPaCa2, AsPC1) IC50 ~20μM 4 days Evaluate the effect of Candesartan cilexetil on the viability of pancreatic cancer cells, showing significant inhibition of cell proliferation. PMC10066340
Caco-2 cells 5, 10, 20, 40, 80 µg/mL 24 hours To evaluate the biocompatibility of candesartan cilexetil and its formulations with Caco-2 cells. Results showed that the IC50 of free CC was 8.5 µg/mL (24 hours), while the IC50 of F7 and C1 niosomes was 29.5 µg/mL, indicating that niosomes reduced the cytotoxicity of the drug. PMC8378936

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Bleomycin-induced pulmonary fibrosis model Oral 10 mg/kg/day Once daily for 21 days Candesartan cilexetil significantly inhibited the increase in total protein and albumin, as well as the increase in total cells and neutrophils in BAL fluid. On day 21 candesartan cilexetil also ameliorated morphological changes and an increased amount of hydroxyproline in lung homogenates. In addition, BLM increased the expression of transforming growth factor (TGF)-β1 in BAL fluid on day 7; this increase was significantly reduced by candesartan cilexetil. PMC1758867
New Zealand White rabbits Atherosclerosis model Oral gavage 0.5 mg/kg/d Once daily for 8 weeks Candesartan attenuated the degree of atherosclerosis, reduced the frequency of plaque disruption and thrombosis, decreased macrophage accumulation within the plaque, and increased collagen deposition. PMC2906248
NSG mice Pancreatic cancer (PANC1) and colorectal cancer (HT29) xenograft models Oral gavage 100 mg/kg Daily administration for the duration of the experiment Evaluate the inhibitory effect of Candesartan cilexetil on tumor growth, showing significant reduction in tumor volume without affecting body weight. PMC10066340
Male KKAy diabetic mice Diabetic model Mixed in diet 0.005% 3 weeks Comparison of the effects of candesartan cilexetil and azilsartan on vascular function in diabetic mice. Candesartan cilexetil did not significantly improve acetylcholine-induced endothelium-dependent relaxation, whereas azilsartan did. PMC3916073
Sprague Dawley rats Hypertension model Oral 50 mg/kg Single dose To evaluate the oral absolute bioavailability of candesartan cilexetil niosomes. Results showed that the bioavailability of F7-SMCC and C1-SMCC was 36.4% and 37.46%, respectively, significantly higher than that of free candesartan cilexetil (6.23%). PMC8378936
UM-HET3 male mice Genetically heterogeneous mouse model Oral 30 ppm Continuous administration starting at 8 months of age Tested the effect of candesartan cilexetil on lifespan; results showed no significant effect on lifespan in either male or female mice PMC8135004

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00319202 Glucose Intolerance ... More >> Obesity Less << Phase 4 Terminated(Difficulties in com... More >>pleting the required sample size) Less << - Colombia ... More >> Fundación Cardiovascular de Colombia Floridablanca, Santander, Colombia, 10000 Less <<
NCT01062451 Methamphetamine Dependence ... More >> Methamphetamine Abuse Substance Abuse Less << Phase 1 Active, not recruiting December 2018 United States, Texas ... More >> Michael E. DeBakey VA Medical Center Houston, Texas, United States, 77030 Less <<
NCT00526279 - Completed - Korea, Republic of ... More >> Research Site Seoul, Jongro-gu, Korea, Republic of Research Site Seoul, Kangnam-gu, Korea, Republic of Research Site Seoul, Songpa-gu, Korea, Republic of Less <<
NCT00802542 - Completed - Latvia ... More >> Research site Daugavpils, Latvia Research site Jelgava, Latvia Research site Liepaja, Latvia Research Site Riga, Latvia Less <<
NCT00564057 HIV Infections ... More >> Hypertension Less << Phase 4 Unknown September 2009 Italy ... More >> University of Insubria, Department of Clinical Medicine Recruiting Varese, Italy, 21100 Less <<
NCT00644475 Essential Hypertension Phase 3 Unknown March 2009 Italy ... More >> University of Pavia Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD    +39 0382 502614    giuseppe.derosa@unipv.it    Contact: Roberto Fogari, MD    +39 0382 526217    r.fogari@unipv.it    Principal Investigator: Giuseppe Derosa, MD Less <<
NCT00150631 Hypertension Phase 3 Unknown December 2014 Denmark ... More >> Karin Skov Aarhus, Denmark, 8000 Less <<
NCT01766505 Hypertension Phase 4 Terminated(lack of the subject... More >>s) Less << - Korea, Republic of ... More >> Chunbuk National University Hospital Chonju, Korea, Republic of, 561-712 Presbyterian Medical Center Chunju, Korea, Republic of, 560-750 Chungnam national university hospital Daejeon, Korea, Republic of, 301-721 The catholic university of Korea, Daejeon st. Mary's Hospital Daejeon, Korea, Republic of, 301-723 Eulji University Hospital Daejeon, Korea, Republic of, 302-799 Konyang university hospital Daejon, Korea, Republic of, 302-718 Chunnam National University Hospital Gwangju, Korea, Republic of, 501-757 Kwangju Christian Hospital Gwangju, Korea, Republic of, 503-715 ST.Carollo hospital Suncheon, Korea, Republic of, 540-719 Less <<
NCT01682564 Hypertension ... More >>Congestive Heart Failure Less << Phase 4 Completed - Korea, Republic of ... More >> Inje university pusan hospital Busan, Busanjin-gu Gaegum-dong, Korea, Republic of, 614-735 Gyeongsang national university hospital Jinju, Chiram-dong, Korea, Republic of, 660-702 Daegu fatima hospital Daegu, Dong-gu Sinam-dong, Korea, Republic of, 701-724 Daedong hospital Busan, Dongnae-gu Myeongnyun-dong, Korea, Republic of, 607-711 Inje university haeundae paik hospital Busan, Haeundae-gu Heaundae-ro 875, Korea, Republic of, 612-030 Maryknoll medical center Busan, Jung-gu Daecheong-dong, Korea, Republic of, 600-730 Keimyung university dongsan medical center Daegu, Jung-gu Dongsan-dong, Korea, Republic of, 700-712 Kyungpook national university hospital Daegu, Jung-gu Samdeok-dong, Korea, Republic of, 700-721 Samsung changwon hospital Changwon, Masanhoiwon-gu Hapseong-dong 50, Korea, Republic of, 630-723 Yeungnam university medical center Daegu, Nam-gu Daemyeong-dong, Korea, Republic of, 705-717 Daegu catholic univ. medical center Daegu, Nam-gu Daemyung-dong, Korea, Republic of, 705-718 Kosin university gospel hospital Busan, Seo-gu Amnam-dong, Korea, Republic of, 602-702 Dong-A university medical center Busan, Seo-gu Dongdaesin-dong, Korea, Republic of, 602-715 Dongguk university gyeongju hospital Gyeongju, Seokjang-dong, Korea, Republic of, 780-350 Less <<
NCT01303783 Hypertension, Essential Phase 2 Completed - -
NCT00459771 Breast Cancer Phase 3 Completed - Netherlands ... More >> Medisch Centrum Alkmaar Alkmaar, Netherlands Flevoziekenhuis Almere, Netherlands The Netherlands Cancer Institute Amsterdam, Netherlands, 1066 CX Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands Slotervaart Hospital Amsterdam, Netherlands Wilhelmina Ziekenhuis Assen, Netherlands Jeroen Bosch Hospital Den Bosch, Netherlands Deventer Ziekenhuis Deventer, Netherlands Medisch Spectrum Twente Enschede, Netherlands Martini Ziekenhuis Groningen, Netherlands University Medical Center Groningen Groningen, Netherlands Ziekenhuis de Tjongerschans Heerenveen, Netherlands Medisch Centrum Leeuwarden Leeuwarden, Netherlands Antonius Ziekenhuis Nieuwegein, Netherlands Canisius-Wilhelmina Hospital Nijmegen, Netherlands UMC St. Radboud Nijmegen, Netherlands VieCuri Medisch Centrum voor Noord-Limburg Venlo, Netherlands Streekziekenhuis Koningin Beatrix Winterswijk, Netherlands Isala Klinieken Zwolle, Netherlands Less <<
NCT00232882 Hypertension Phase 4 Completed - Canada, Quebec ... More >> Institut de Recherches Cliniques de Montréal Montréal, Quebec, Canada, H2W 1R7 Less <<
NCT00884663 Migraine Without Aura ... More >> Migraine With Aura Chronic Migraine Less << Phase 2 Phase 3 Completed - Norway ... More >> Norwegian National Headache Centre, St. Olavs University Hospital Trondheim, Norway, 7489 Less <<
NCT02064556 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of Less <<
NCT00244634 Pediatric Hypertension Phase 3 Completed - -
NCT02521246 Essential Arterial Hypertensio... More >>n Less << Phase 3 Withdrawn(Sponsor decision) August 2017 -
NCT02707224 Healthy Phase 1 Completed - -
NCT02609711 Healthy Male Subjects PHASE1 UNKNOWN - Inha Univ. Hospital, Incheon, ... More >>Korea, Republic of Less <<
NCT02079506 Healthy Phase 1 Completed - Korea, Republic of ... More >> Chungnam National University Hospital Jung-gu, Daejeon, Korea, Republic of, 301-721 Less <<
NCT02651870 Hypertension Phase 3 Unknown February 2016 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Dong-Hoon Choi, M.D., Ph.D          Principal Investigator: Dong-Hoon Choi, M.D, Ph.D Less <<
NCT00282178 Hypertension ... More >>Obesity Less << Phase 2 Completed - Sweden ... More >> Umeå University Hospital Umeå, Sweden, SE-90185 Less <<
NCT02521233 Essential Arterial Hypertensio... More >>n Less << Phase 3 Withdrawn(Sponsor decision) August 2017 -
NCT00608153 - Completed - -
NCT01135212 Hypertension Phase 3 Completed - Korea, Republic of ... More >> KyungPook National University Hospital Daegu, Korea, Republic of, 110-750 Less <<
NCT00244595 Hypertension Phase 3 Completed - -
NCT00607633 - Completed - -
NCT01152567 - Completed - -
NCT00125463 Hypertension|Cardiovascular Di... More >>seases Less << PHASE3 UNKNOWN 2025-12-05 Kyoto University, Kyoto, Yoshi... More >>dakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan Less <<
NCT03688633 Peripheral Neuropathy Phase 2 Not yet recruiting June 1, 2021 France ... More >> CHU Limoges Not yet recruiting Limoges, France, 87042 Contact: Laurent Magy, MD    05 55 05 65 68    laurent.magy@unilim.fr Less <<
NCT00573742 - Completed - Romania ... More >> Research Site Bacau, Romania Research Site Braila, Romania Research Site Brasov, Romania Research Site Bucuresti, Romania Research Site Cluj, Romania Research Site Constanta, Romania Research Site Craiova, Romania Research Site Galati, Romania Research Site Ghiroda, Romania Research Site Iasi, Romania Research Site Lugoj, Romania Research Site Oradea, Romania Research Site Pitesti, Romania Research Site Ploiesti, Romania Research Site Sibiu, Romania Research Site Timisoara, Romania Less <<
NCT02261116 Healthy Phase 4 Completed - -
NCT00184587 Cluster Headache Phase 2 Completed - Norway ... More >> Norwegian National Headache Centre St.Olavs Hospital Trondheim, Norway, 7006 Less <<
NCT00905333 Healthy Phase 1 Completed - Brazil ... More >> Research Site Itatiba, SP, Brazil Research Site Americana, Brazil Less <<
NCT00679484 Chronic Heart Failure ... More >> High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level Less << Phase 3 Terminated(Lack of subject rec... More >>ruitment) Less << - France ... More >> Bron, France Cedex, France Cholet, France Langres, France Mannheim, France Pontoise, France Roubaix, France Germany Bad Nauheim, Germany Berlin, Germany Lambrecht, Germany Netherlands Ad Delft, Netherlands Less <<
NCT02548286 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Chungnam National University Hospital Daejeon, Jung-gu, Korea, Republic of Less <<
NCT00108706 Cerebrovascular Accident ... More >> Acute Stroke Less << Phase 4 Unknown - United Kingdom ... More >> Sunderland Royal Hospital Sunderland, Tyne and Wear, United Kingdom, SR4 7TP Less <<
NCT02186496 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Chungnam National University Hospital Daejeon, Chungcheongbuk-do, Korea, Republic of, 301-721 Less <<
NCT03231982 Hypertension Phase 4 Recruiting May 31, 2019 Korea, Republic of ... More >> Yonsei University Severance Cardiovascular Hospital Recruiting Seoul, Korea, Republic of Contact: Donghoon Choi, M.D., Ph.D.    82-2-2228-8200    cdhlyj@yuhs.ac Less <<
NCT00775814 Obesity Hyper... More >>tension Less << Phase 4 Completed - Germany ... More >> Bad Dürrheim, Baden-Württemberg, Germany Balingen, Baden-Württemberg, Germany Deggingen, Baden-Württemberg, Germany Rottweil, Baden-Württemberg, Germany Spaichingen, Baden-Württemberg, Germany Ingolstadt, Bayern, Germany München, Bayern, Germany Passau, Bayern, Germany Schauenburg, Hessen, Germany Bocholt, Nordrhein-Westfalen, Germany Essen, Nordrhein-Westfalen, Germany Isselburg, Nordrhein-Westfalen, Germany Köln, Nordrhein-Westfalen, Germany Roetgen, Nordrhein-Westfalen, Germany Troisdorf, Nordrhein-Westfalen, Germany Wesseling, Nordrhein-Westfalen, Germany Roedersheim-Gronau, Rheinland-Pfalz, Germany Dresden, Sachsen, Germany Freital, Sachsen, Germany Machem, Sachsen, Germany Markkleeberg, Sachsen, Germany Wermsdorf, Sachsen, Germany Bad Segeberg, Schleswig-Holstein, Germany Berlin, Germany Less <<
NCT01227603 Hypertension, Essential Phase 1 Completed - Germany ... More >> Köln, Nordrhein-Westfalen, Germany, 51063 Less <<
NCT00400582 Heart Failure Phase 4 Completed - Canada, Quebec ... More >> Montreal Heart Institute Montreal, Quebec, Canada, H1T 1C8 Less <<
NCT02811731 Hypertension Phase 1 Completed - -
NCT02988362 Hypertension Phase 1 Unknown March 2017 -
NCT01629225 Essential Hypertension Phase 4 Unknown July 2015 China ... More >> Department of Cardiology, Daping Hospital, The Third Military Medical University Recruiting Chongqing, China, 400042 Contact: Yu Changqing, MD       changqingyu-2@163.com Less <<
NCT02801526 Hypertension Phase 1 Completed - -
NCT00843154 Heart Failure Phase 3 Terminated(Insufficient enroll... More >>ment) Less << - -
NCT02944734 Essential Hypertension Phase 2 Completed - Korea, Republic of ... More >> Catholic University of Korea Bucheon St. Mary's Hospital Wonmi-gu, Bucheon, Korea, Republic of Inje University Busan Paik Hospital Busanjin-gu, Busan, Korea, Republic of Pusan National University Hospital Seo-gu, Busan, Korea, Republic of Keimyung University Dongsan Medical Center Joong-gu, Daegu, Korea, Republic of Kyungpook National University Hospital Joong-gu, Daegu, Korea, Republic of Daegu Catholic University Medical Center Nam- gu, Daegu, Korea, Republic of Dongguk University Ilsan Hospital Ilsandong-gu, Goyang-si, Gyeoggi-do, Korea, Republic of Chonnam National University Hospital Dong-Gu, Gwangju, Korea, Republic of Catholic University of Korea Uijeongbu St. Mary's hospital Uijeongbu-si, Gyeoggi-do, Korea, Republic of Gachon University Gil Hospital Namdong-gu, Incheon, Korea, Republic of St. Carollo General Hospital Suncheon-si, Jeollanam-do, Korea, Republic of Wonju Severance Christian Hospital Wonju, Kangwon-Do, Korea, Republic of Catholic University of Korea St. Paul's Hospital Dongdaemun-gu, Seoul, Korea, Republic of KyungHee University Medical Center Dongdaemun-gu, Seoul, Korea, Republic of Hallym University Kangdong Sacred Heart Hospital Gangdong-gu, Seoul, Korea, Republic of Kyung Hee University Hospital at Gangdong Gangdong-Gu, Seoul, Korea, Republic of VHS( Veterans Medical Service) Medical Center Gangdong-gu, Seoul, Korea, Republic of Konkuk University Medical Center Gwangjin-gu, Seoul, Korea, Republic of Seoul National University Hospital Jongro-gu, Seoul, Korea, Republic of Catholic University of Korea Seoul St. Mary's Hospital Seocho-Gu, Seoul, Korea, Republic of Korea University Anam Hospital Seongbuk-Gu, Seoul, Korea, Republic of Catholic University of Korea Yeouido St. Mary's Hospital Yeongdeungpo-gu, Seoul, Korea, Republic of Ulsan University Hospital Dong-gu, Ulsan, Korea, Republic of Less <<
NCT00775840 Heart Failure Phase 3 Completed - Germany ... More >> Bad Friedrichshall, Baden-Württemberg, Germany Heidelberg, Baden-Württemberg, Germany Ludwigsburg, Baden-Württemberg, Germany Bad Homburg, Hessen, Germany Bad Nauheim, Hessen, Germany Darmstadt, Hessen, Germany Frankfurt, Hessen, Germany Giessen, Hessen, Germany Kassel, Hessen, Germany Limburg, Hessen, Germany Melsungen, Hessen, Germany Mühlheim, Hessen, Germany Wiesbaden, Hessen, Germany Nienburg, Niedersachsen, Germany Northeim, Niedersachsen, Germany Weyhe, Niedersachsen, Germany Essen, Nordrhein-Westfalen, Germany Gelsenkirchen, Nordrhein-Westfalen, Germany Gladbeck, Nordrhein-Westfalen, Germany Langenfeld, Nordrhein-Westfalen, Germany Paderborn, Nordrhein-Westfalen, Germany Siegen, Nordrhein-Westfalen, Germany Bad Kreuznach, Rheinland-Pfalz, Germany Neukirchen, Saarland, Germany Coswig, Sachsen-Anhalt, Germany Dresden, Sachsen, Germany Hartmannsdorf, Sachsen, Germany Leipzig, Sachsen, Germany Leisnig, Sachsen, Germany Machem, Sachsen, Germany Markkleeberg, Sachsen, Germany Riesa, Sachsen, Germany Wermsdorf, Sachsen, Germany Erfurt, Thüringen, Germany Jena, Thüringen, Germany Nordhausen, Thüringen, Germany Berlin, Germany Less <<
NCT00620178 - Completed - Sweden ... More >> Research Site Uppsala, Sweden Less <<
NCT00634400 Congestive Heart Failure Phase 3 Completed - -
NCT00120003 Stroke Phase 3 Completed - Norway ... More >> Ullevaal University Hospital Oslo, Norway, NO-0407 Less <<
NCT01611077 Hypertension Phase 4 Completed - Germany ... More >> Praxis Dr. Reimer Anderbeck, Germany, 38836 Praxis Dr. Heinz Bergisch-Gladbach, Germany, 51429 Praxis Dr. Zemmrich Berlin, Germany, 12043 St.-Josefs-Hospital Cloppenburg, Germany, 49661 Praxis Dr. Pohl Dresden, Germany, 01129 Praxis Dr. Koßler-Wiesweg Essen, Germany, 45138 Praxis Dr. Rövenich Frankfurt, Germany, 65929 Praxis Dr. Strzata Kapellendorf, Germany, 99510 Praxis Dr. Paschmionka Leipzig, Germany, 04316 Praxis Dr. Pitule Ludwigshafen, Germany, 67061 Praxis Dr. Loddo Rastede, Germany, 26180 Less <<
NCT00383929 Hypertension Phase 3 Completed - -
NCT01827202 Hypertension ... More >>Chronic Kidney Disease Proteinuria Less << Phase 4 Completed - Austria ... More >> Medical University of Vienna, Department of Internal Medicine III, Division of Nephrology and Dialysis Vienna, Austria, 1090 Less <<
NCT00348686 - Completed - -
NCT00348686 Hypertension ... More >>Left Ventricular Hypertrophy Less << Phase 4 Completed - Korea, Republic of ... More >> Research Site BuSan, Korea, Republic of Research Site CheonAn, Korea, Republic of Research Site CheongJu, Korea, Republic of Research Site Chunbuk, Korea, Republic of Research Site DaeGu, Korea, Republic of Research Site DaeJeon, Korea, Republic of Research Site Gyungsangnamdo, Korea, Republic of Research Site JeonJu, Korea, Republic of Research Site KwangJu, Korea, Republic of Research Site Pusan, Korea, Republic of Research Site Ulsan, Korea, Republic of Less <<
NCT02059616 Essential Hypertension Phase 2 Unknown December 2015 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Bundang, Korea, Republic of Dong-A University Hospital Recruiting Busan, Korea, Republic of Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of Konyang University Hospital Recruiting Daejeon, Korea, Republic of Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Inje University Ilsan Paik Hospital Recruiting Ilsan, Korea, Republic of Inha University Hospital Recruiting Incheon, Korea, Republic of Hallym University Sacred Heart hospital Recruiting Kyungki-do, Korea, Republic of Inje University Haeundae Baik Hospital Recruiting Pusan, Korea, Republic of Pusan National University Hospital Recruiting Pusan, Korea, Republic of Asan Medical Center Recruiting Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Seoul Medical Center Recruiting Seoul, Korea, Republic of Seoul St. Mary's hospital Recruiting Seoul, Korea, Republic of Severance Hospital Recruiting Seoul, Korea, Republic of Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of Yonsei University Gangnam Severance Hospital Recruiting Seoul, Korea, Republic of Ajou University Hospital Recruiting Suwon, Korea, Republic of Principal Investigator: Seung-Jea Tahk          Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of Less <<
NCT01806311 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Chungnam national university hospital,clinical trial center Daejeon, Chungcheongbul-do, Korea, Republic of, 301-721 Less <<
NCT02173912 Healthy Volunteers Phase 1 Unknown August 2014 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Chaeyeong Lee          Principal Investigator: Jae-Wook Ko, MD Less <<
NCT02969265 Hypertension Phase 3 Withdrawn(Business reasons unr... More >>elated to product safety) Less << July 26, 2018 -
NCT01984164 Hypertension ... More >>Mild Cognitive Impairment Less << Phase 3 Active, not recruiting December 15, 2018 United States, Georgia ... More >> Emory Univeristy Atlanta, Georgia, United States, 30329 Less <<
NCT02047019 Hypertension Phase 3 Withdrawn(GPDC decided to term... More >>inate the study) Less << December 8, 2019 Italy ... More >> Fondazione Università G.D'Annunzio Chieti, Abruzzo, Italy, 66100 A.O.U. di Bologna Policlinico S.Orsola Malpighi Bologna, Emilia-Romagna, Italy, 40138 AAS 3 Friuli Alto Medio Collin Udine, Friuli-Venezia Giulia, Italy, 33038 Fondazione Salvatore Maugeri Pavia, Lombardia, Italy, 27100 IRCCS Ist Neurologico Mediterraneo Isernia, Molise, Italy, 86077 A.O.U. di Sassari Sassari, Sardegna, Italy, 07100 A.O.U. Pisana Pisa, Toscana, Italy, 56126 AULSS 07 Pieve Soligo Treviso, Veneto, Italy, 31029 Less <<
NCT03460327 - Recruiting October 2026 Norway ... More >> St. Olavs University Hospital Recruiting Trondheim, Norway Contact: Magnus Strømmen, MSc Less <<
NCT00984529 - Completed - Croatia ... More >> Research Site Biograd, Croatia Research Site Bjelovar, Croatia Reserach Site Cakovec, Croatia Research Site Karlovac, Croatia Reserach Site Krapinske Toplice, Croatia Research Site Novi Marof, Croatia Research Site Opatija, Croatia Research Site Osijek, Croatia Research Site Pula, Croatia Research Site Rijeka, Croatia Reserach Site Sl. Brod, Croatia Research Site Split, Croatia Research Site Stubicke Toplice, Croatia Reserach Site Zabok, Croatia Research Site Zagreb, Croatia Less <<
NCT00244621 - Completed - -
NCT00699452 Aortic Valve Stenosis Phase 3 Unknown December 2014 Finland ... More >> Division of Cardiology, Helsinki University Central Hospital Recruiting Helsinki, Finland, 00029 Contact: Markku Kupari, MD, PhD    358-9-4717-2441    markku.kupari@hus.fi    Contact: Satu Helske, MD, PhD    358-9-681-411    satu.helske@wri.fi    Principal Investigator: Markku Kupari, MD, PhD Less <<
NCT00434967 Hypertension Phase 3 Completed - Belgium ... More >> Research Site Dour, Belgium Research Site Gozée, Belgium Research Site Hasselt, Belgium Research Site Linkebeek, Belgium Research Site Marchovelette, Belgium Research Site Ronquières, Belgium Research Site Saint-Médard, Belgium Research Site Steenokkerzel, Belgium Latvia Research Site Daugavpils, Latvia Research Site Ogre, Latvia Research Site Riga, Latvia Malta Research Site Gozo, Malta Research Site Gwardiamangia, Malta Romania Research Site Arad, Romania Research Site Bucuresti, Romania Research Site Iasi, Romania Research Site Pitesti, Romania Research Site Ploiesti, Romania Research Site Targoviste, Romania Research Site Timisoara, Romania Russian Federation Research Site Moscow, Russian Federation Research Site St. Petersburg, Russian Federation Slovakia Research Site Bratislava, Slovakia Research Site Levice, Slovakia Research Site Lucenec, Slovakia Research Site Presov, Slovakia Research Site Sahy, Slovakia Less <<
NCT00434967 - Completed - -
NCT00244621 Hypertension Phase 3 Completed - -
NCT01938664 Cocaine Dependence Phase 2 Completed - United States, Texas ... More >> Michael E. DeBakey VA Medical Center Houston, Texas, United States, 77030 Less <<
NCT02068495 - Completed - -
NCT00690612 Hypertension Phase 3 Completed - Belgium ... More >> Research Site Edegem, Belgium Research Site Gent, Belgium France Research Site Strasbourg Cedex, France Germany Research Site Erlangen, Germany Research Site Heidelberg, Germany Research Site Marburg, Germany Research Site Rostock, Germany Italy Research Site Genova, GE, Italy Research Site Padova, PD, Italy Poland Research Site Gda�sk, Poland Research Site Krakow, Poland Ukraine Research Site Crimea, Ukraine Research Site Kyiv, Ukraine Less <<
NCT01350609 Hypertension, Essential Phase 1 Completed - Germany ... More >> Berlin, Germany, 13353 Less <<
NCT02068495 - Completed - -
NCT00679640 - Completed - -
NCT00139386 Hypertension ... More >>Coronary Artery Disease Less << Phase 4 Completed - Japan ... More >> Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto, Japan, 860-8556 Less <<
NCT02094924 Hypertension Phase 1 Completed - India ... More >> GSK Investigational Site Hyderabad, India, 500 013 Less <<
NCT00634309 Congestive Heart Failure Phase 3 Completed - -
NCT00690612 - Completed - -
NCT03136666 Clinical Pharmacology Phase 1 Completed - Germany ... More >> Wuppertal, Nordrhein-Westfalen, Germany, 42096 Less <<
NCT00573430 Non-diabetic Nephropathy With ... More >>Hypertension Less << Phase 4 Completed - Korea, Republic of ... More >> Research Site Seoul, Korea, Republic of Less <<
NCT00634712 Congestive Heart Failure Phase 3 Completed - -
NCT00844324 Hypertension Phase 1 Completed - United Kingdom ... More >> Research Site Harrow, United Kingdom Less <<
NCT01976572 Hyperphosphatemia ... More >> Chronic Kidney Disease Less << Phase 1 Completed - United Kingdom ... More >> Covance Clinical Research Unit Ltd. Leeds, Springfield House Hyde Street, United Kingdom Less <<
NCT00573430 - Completed - -
NCT00990639 Alcoholic Liver Disease Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Yonsei University Wonju College of Medicine Wonju Christian Hospital Wonju, Kangwon-do, Korea, Republic of, 220-701 Less <<
NCT01976572 - Completed - -
NCT00252720 Type 1 Diabetes Phase 3 Completed - -
NCT00252720 - Completed - -
NCT00227318 Hypertension Phase 3 Completed - -
NCT01788358 Hypertension Phase 3 Completed - -
NCT00252694 - Completed - -
NCT00252733 Type 1 Diabetes Phase 3 Completed - Australia ... More >> Research Site Herston, Australia Research Site Perth, Australia Denmark Research Site Odense, Denmark Less <<
NCT02016183 - Completed - Japan ... More >> Tokyo, Japan Less <<
NCT00252694 Type 2 Diabetes Phase 3 Completed - -
NCT01788358 - Completed - -
NCT01012479 Hypertension Phase 4 Completed - Germany ... More >> Berlin, Germany Blankenhain, Germany Dortmund, Germany Hamburg, Germany Köthen, Germany Löhne, Germany Nürnberg, Germany Remscheid, Germany Rodgau, Germany Stockach, Germany Wardenburg, Germany Weinheim, Germany Ukraine Ivano-Frankivsk, Ukraine Kharkiv, Ukraine Kiev, Ukraine Lviv, Ukraine Less <<
NCT02016183 - Completed - -
NCT00252733 - Completed - -
NCT00621153 - Completed - -
NCT00621153 Stage II Hypertension Phase 4 Completed - Korea, Republic of ... More >> Research Site Seoul, Korea, Republic of Less <<
NCT00242346 Proteinuria Phase 3 Completed - Canada, Alberta ... More >> Research Site Calgary, Alberta, Canada Research Site Edmonton, Alberta, Canada Canada, British Columbia Research Site Kelowna, British Columbia, Canada Research Site Vancouver, British Columbia, Canada Canada, Manitoba Research Site Winnipeg, Manitoba, Canada Canada, Newfoundland and Labrador Research Site St. John, Newfoundland and Labrador, Canada Canada, Nova Scotia Research Site Halifax, Nova Scotia, Canada Canada, Ontario Research Site Courtice, Ontario, Canada Research Site Kitchener, Ontario, Canada Research Site London, Ontario, Canada Research Site Mississauga, Ontario, Canada Research Site Oakville, Ontario, Canada Research Site Oshawa, Ontario, Canada Research Site Richmond Hill, Ontario, Canada Research Site Scarborough, Ontario, Canada Research Site Sudbury, Ontario, Canada Research Site Thunder Bay, Ontario, Canada Research Site Timmins, Ontario, Canada Research Site Toronto, Ontario, Canada Research Site Weston, Ontario, Canada Canada, Quebec Research Site Greenfield Park, Quebec, Canada Research Site Laval, Quebec, Canada Research Site Montreal, Quebec, Canada Research Site Quebec City, Quebec, Canada Research Site Ste-Foy, Quebec, Canada Canada, Saskatchewan Research Site Saskatoon, Saskatchewan, Canada Less <<
NCT02368665 Essential Hypertension Phase 3 Unknown June 2016 Korea, Republic of ... More >> Hallym University Sungsim Hospital Recruiting Anyang-si, Korea, Republic of Inje University Busan Baik Hospital Recruiting Busan, Korea, Republic of Inje University Haeundae Baik Hospital Recruiting Busan, Korea, Republic of Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Inje University Ilsan Baik Hospital Recruiting Ilsan, Korea, Republic of Inha University Hospital Recruiting Incheon, Korea, Republic of Seoul National University Bundang Hospital Recruiting Seongnam-si, Korea, Republic of Asan Medical Center Recruiting Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of Gangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Seoul Medical Center Recruiting Seoul, Korea, Republic of Seoul St. Mary's Hospital Catholic University Recruiting Seoul, Korea, Republic of Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of Yonsei University Severance Hospital Recruiting Seoul, Korea, Republic of Ajou University Hospital Recruiting Suwon, Korea, Republic of Principal Investigator: Seungjae Tahk          Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of Less <<
NCT02646982 Mild Cognitive Impairment Phase 2 Recruiting September 2021 United States, Georgia ... More >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Ihab Hajjar, MD    404-712-7250    ihajjar@emory.edu    Principal Investigator: Ihab Hajjar, MD          Wesley Woods Center Recruiting Atlanta, Georgia, United States, 30329 Contact: Ihab Hajjar, MD    404-712-7250    ihajjar@emory.edu Less <<
NCT01926652 Healthy Phase 1 Completed - Korea, Republic of ... More >> Chungnam national university hospital, clinical trial center Daejeon, Chungcheongbul-do, Korea, Republic of, 301-721 Less <<
NCT02254447 Cardiovascular Disease Phase 1 Completed - India ... More >> GSK Investigational Site Hyderabad, India, 500 013 Less <<
NCT02368652 Essential Hypertension Phase 3 Unknown June 2016 Korea, Republic of ... More >> Hallym University Sungsim Hospital Recruiting Anyang-si, Korea, Republic of Inje University Busan Baik Hospital Recruiting Busan, Korea, Republic of Inje University Haeundae Baik Hospital Recruiting Busan, Korea, Republic of Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Inje University Ilsan Baik Hospital Recruiting Ilsan, Korea, Republic of Inha University Hospital Recruiting Incheon, Korea, Republic of Seoul National University Bundang Hospital Recruiting Seongnam-si, Korea, Republic of Asan Medical Center Recruiting Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of Gangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Seoul Medical Center Recruiting Seoul, Korea, Republic of Seoul St. Mary's Hospital Catholic University Recruiting Seoul, Korea, Republic of Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of Yonsei University Severance Hospital Recruiting Seoul, Korea, Republic of Ajou University Hospital Recruiting Suwon, Korea, Republic of Principal Investigator: Seungjae Tahk          Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of Less <<
NCT02064621 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of Less <<
NCT02006602 Hypertension Phase 1 Completed - India ... More >> GSK Investigational Site Hyderabad, India, 500 013 Less <<
NCT01845272 Healthy Phase 1 Unknown August 2013 -
NCT02166697 - Completed - -
NCT02166697 - Completed - -
NCT02211638 - Completed - -
NCT02211638 - Completed - Japan ... More >> Osaka, Japan Less <<
NCT02006589 Hypertension Phase 1 Completed - India ... More >> GSK Investigational Site Hyderabad, India, 500 013 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.64mL

0.33mL

0.16mL

8.19mL

1.64mL

0.82mL

16.38mL

3.28mL

1.64mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories